ITEM#: 2918-4343S
MFR#: 4343_S
Anti-ARMETL1 Rabbit Polyclonal Antibody - 4343_S, 0.02 mg
Product Name | Description | Item# | QTY | |
---|---|---|---|---|
PAB RABBIT CDNF HU/MS/RAT IGG PRFD 100UG | Anti-CDNF Rabbit Polyclonal Antibody - 4343, 0.1 mg | 2918-4343 | EA | |
CDNF ANTIBODY 4345_S | Anti-ARMETL1 Rabbit Polyclonal Antibody - 4345_S, 0.02 mg | 2918-4345S | EA | |
CDNF RECOMBINANT PROTEIN | Human Recombinant Cdnf (from E. coli) - 40-550, 0.005 mg | 2918-40550 | EA | |
PEPTIDE CDNF HUMAN C-TERMINUS 9AA 50UG | Human CDNF Peptide (9 aa near C-terminus) - 4343P, 0.05 mg | 2918-4343P | EA | |
CDNF ANTIBODY | CDNF, Host Species: Rabbit, Target Species: Human, Polyclonal, Immunohistochemistry, Western Blot, Primary, 0.1 mg/mL, Unconjugated, 100 uL, Liquid, PBS with 40% glycerol and 0.02% sodium azide; pH 7.2, Q49AH0 | 3136-PA560764 | EA | |
CDNF ANTIBODY | CDNF, Host Species: Goat, Target Species: Mouse, Polyclonal, Western Blot, Immunohistochemistry (Frozen), Primary, 0.2 mg/mL, Unconjugated, 100 ug, Lyophilized, PBS with 5% trehalose and No Preservative, Cdnf, Q8CC36 | 3136-PA547708 | EA | |
Anti-CDNF (ab1) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | Anti-CDNF (ab1) antibody produced in rabbit affinity isolated antibody, buffered aqueous solution | 3042-PRS4343100UG | EA | |
CDNF MONOCLONAL ANTIBODY D2 | CDNF, Host: Mouse, Applications: IHC (P), WB, Clone: D2, Species Reactivity: Hu, Monoclonal, Primary, 1 mg/mL, 100 uL, Unconjugated, Invitrogen | 3136-MA543892 | EA | |
CDNF (AB1) Blocking Peptide for PRS4343 | CDNF (AB1) Blocking Peptide for PRS4343 | 3042-SBP4343005MG | EA |
Thank you for visiting, your account is pending approval.
You will received email notification for approval within 24hrs.
Contact customerservice@franklinyoung.com for any questions.
Thank you for requesting an account with Franklin Young.
Your request has been declined
We restrict website access to government entities, and related customers.
Please contact customerservice@franklinyoung.com with any questions.